The use of cytosine arabinoside (Ara-C) infused at kinetically suggested intervals is reported in 40 pediatric patients with acute myelogenous leukemia (AML) and its subtypes. Response was observed in 17 of the 34 evaluable patients. However, the severe, often fatal effects of the regimen prevent its recommendation as a standard induction regimen in AML in children.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mpo.2950040410 | DOI Listing |
Publication Analysis
Top Keywords
acute myelogenous
8
myelogenous leukemia
8
cytosine arabinoside
8
remission induction
4
induction acute
4
leukemia cytosine
4
arabinoside synchronization
4
synchronization southwest
4
southwest oncology
4
oncology group
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!